三优生物 Sanyou Bio
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Meet Clicklinks: The Innovation Hub for Original Drug Discovery 2026-05-23 22:00
Sanyou Bio Launches SAI-DA 1.0, the AI-Drug Accelerator 2026-05-20 22:00
Major breakthrough of Sanyou Biopharmaceuticals AI-STAL 2026-05-18 22:00
Clicklinks | 14-Day Candidate Antibody Discovery - Sanyou AI-STAL 2.0 Defines the Era of Ultimate Speed in Drug Molecule Discovery 2026-04-15 22:00
Sanyou Milestone | Recognized as a "Shanghai Municipal Enterprise Technology Center," Further Validating for Innovation Excellence 2026-03-30 22:00
Sanyou Biopharmaceuticals Announces New Strategic Investor; Liferiver Biotech Increases Its Stake, and Gree Group's Yanghe Investment Joins as a Strategic Shareholder 2026-02-24 22:00
Sanyou Biopharmaceuticals Lang Guojun: Making Innovative Biologics R&D Easier for Clients Worldwide 2026-02-12 22:00
On Site: "2026 China Forum on Source Innovation in New Drug Discovery" Concludes Successfully 2026-02-10 21:07
Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery" 2026-01-31 16:15
Strategic Partnership | Sanyou Bio and KanryBio Forge Partnership to Co-Develop Key Reagents and Products for Biomarker Assay Kits 2025-12-12 22:00
Strategic Partnership | Sanyou Bio and Korea's FatiAbGen Join Forces to Expand the Global Biopharma Market 2025-11-27 22:00
Strategic Partnership Between Sanyou Bio and Yugong Bio to Accelerate Expansion in High-End Synthetic Enzyme Market 2025-11-11 22:00
Sanyou Bio and Shanghai ZJ Bio-Tech Sign Strategic Cooperation Agreement on Automated Development of Innovative Biologics to Jointly Tackle R&D Bottlenecks and Provide New Momentum for Innovative Drug R&D 2025-11-03 22:00
Sanyou Bio Wins the "2025 Best Customer Satisfaction CRO Award" 2025-08-05 22:00
Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates 2025-06-10 18:00
Strategic Partnership | Sanyou Bio and TransRecoBio Forge Strategic Alliance to Build a New Ecosystem for the Full Industry Chain 2025-05-13 18:00
SanyouBio Launches 73 Whole-Series Bispecific Reference Antibody Products, Facilitating New Breakthroughs in Bispecific Drug Development 2025-03-05 20:00
Review and Outlook of Sanyou Bio Intelligent Super-trillion Molecule Discovery Platform 2025-02-23 18:00
From 0 to 100 Trillion: The Rise of Sanyou Bio's Intelligent Molecule Library 2025-02-05 18:00
Another star technology platform of the Sanyou AI-STAL family 2024-12-06 18:30
1 2 3